Scientists at the Gladstone Institutes discovered that changing a specific part of the huntingtin protein prevented the loss of critical brain cells and protected against behavioral
symptoms in a mouse model of the disease.
Changing a specific part of the huntingtin protein prevented the loss of critical brain cells and protected against behavioral
symptoms in a mouse model of the disease.
MIT's Li - Huei Tsai, Ed Boyden, and their colleagues have shown that stimulating neurons to produce gamma waves at a frequency of 40 Hz reduces the occurrence and severity of several Alzheimer's - associated
symptoms in a mouse model of the disease.
Not exact matches
Gene therapy delivered to a specific part
of the brain reverses
symptoms of depression
in a
mouse model of the
disease — potentially laying the groundwork for a new approach to treating severe cases
of human depression
in which drugs are ineffective.
Antibiotic treatment reduced motor deficits and molecular hallmarks
of Parkinson's
disease in a
mouse model, whereas transplantation
of gut microbes from patients with Parkinson's
disease exacerbated
symptoms in these
mice.
With these cells
in hand, the researchers injected them into the lacrimal glands
of mouse models of Sjogren's syndrome, an autoimmune
disease that results
in ADDE, dry mouth and other
symptoms.
Using a
model of Parkinson's
disease in which the toxin MPTP, made famous
in book «The Case
of the Frozen Addicts,» induces Parkinson's - like
symptoms in humans and
mice, Dr. Smeyne showed that
mice infected with H1N1, even long after the initial infection, had more severe Parkinson's
symptoms than those who had not been infected with the flu.
Several laboratories, including one led by Stewart Anderson
of the University
of Pennsylvania Perelman School
of Medicine, have demonstrated that transplanting inhibitory neurons from healthy
mice has improved
symptoms in mice with
models of those
diseases.
The work recently received a $ 1.7 million National Institutes
of Health grant to delve into the mechanisms that occur as the cells reprogram, and to employ the cells for treating the Parkinson's - like
symptoms in a
mouse model of hypomyelinating
disease.
The 120 repeat R6 / 2
mouse model of HD expresses a human transgene containing exon 1
of the mutant huntingtin gene and faithfully replicates many
of the
symptoms of the
disease, including progressive loss
of body weight, marked impairments
in cognition, and severe motor deficits.
Using a
mouse model for this
disease, which
in humans involves the destruction
of white matter
in the brain, a research team led by Albee Messing, director
of the UW — Madison Waisman Center, found that a protein behind the
symptoms of the
disease, called GFAP, is broken down more rapidly
in the body than researchers previously found
in cell culture studies.